Advertisement

Rising Cost Of PrEP To Prevent HIV Infection Pushes It Out Of Reach For Many

Gilead Sciences makes Truvada, a medicine known generically as "pre-exposure prophylaxis," or PrEP. Consistent, daily doses of the drug are thought to reduce the risk of getting HIV from sex by more than 90 percent. (Paul Sakuma/AP)
Gilead Sciences makes Truvada, a medicine known generically as "pre-exposure prophylaxis," or PrEP. Consistent, daily doses of the drug are thought to reduce the risk of getting HIV from sex by more than 90 percent. (Paul Sakuma/AP)

Related:

Advertisement

More from WBUR

Listen Live
Close